BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220318T090000
DTEND;TZID=Europe/Stockholm:20220318T093000
DTSTAMP:20260404T044302
CREATED:20220117T165753Z
LAST-MODIFIED:20220308T081854Z
UID:61233-1647594000-1647595800@www.scilifelab.se
SUMMARY:True precision medicine in immuno-oncology\, challenges\, and opportunities
DESCRIPTION:Sara Mangsbo\, biträdande universitetslektor vid institutionen för farmaceutisk biovetenskap\, Immunonkologi.\n\n\n\n\n\nOn March 18\, Uppsala University Associate Professor Sara Mangsbo will talk about how the future of cancer therapy is becoming personal. Sara co-founded Strike Pharma to further develop the Uppsala University and SciLifeLab Drug Discovery platform co-developed ADAC technology (Adaptable Drug Affinity Conjugates).  \n\n\n\nWith current diagnostic tools also\, immunotherapy can and should enter the omics-field and the developed delivery platform envisions a truly patient tailored neoantigen cancer vaccine strategy\, ensuring that the body becomes the factory to generate tumor-specific T cells\, that can find and destroy tumor cells regardless of the location in the body. With a cost and time efficient “True Precision Medicine” approach\, tailored therapeutics will be a realistic future\, ultimately lowering the healthcare burden for a sustainable future. \n\n\n\nSara Mangsbo \n\n\n\nregister to receive zoom link\n\n\n\nSara Mangsbo is a Senior Lecturer in Antibody Drugs at Uppsala University at the Department of Pharmacy. She has her education background with a PhD in Clinical Immunology Uppsala University. Sara has since completed her postdoctoral studies at Leiden University Medical Center and started her own research group at Uppsala University in 2016. Her work focuses on the development and immunological characterization of novel immunotherapies and therapeutic combination strategies for drug discovery. Sara has previously also held a brand lead position in Immuno-oncology at Astra Zeneca’s marketing division and co-founded the drug development and service company startups Immuneed AB and VivoLogica AB (current board member). The drug development platform from Immuneed was acquired by the Norwegian pharmaceutical company Ultimovacs in 2018.  \n\n\n\nIn late 2020\, Sara co-founded Strike Pharma AB. Strike Pharma develops a novel next generation Antibody-Drug Conjugate (ADC) technology\, the ADAC technology. ADACs are short for Adaptable Drug Affinity Conjugates and are built to improve deliver tailored made synthetic peptides to specific cell types for improved immune modulation. Using the ADAC platform\, efficient delivery and extended half-life of patient tailored peptide therapeutics will ensure that the body becomes the factory\, producing billions of T cells that can find and destroy tumors cells regardless of the location in the body. \n\n\n\n\n\n\n\n\n\n\n\n“Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations . \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSeason 5\, will be held September 2021 until March 2022 with scheduled Talks\, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.
URL:https://www.scilifelab.se/event/true-precision-medicine/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
END:VCALENDAR